Skip to main content
Published locations for ARCHES: Enzalutamide improves mHSPC survival regardless of baseline PSA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
ARCHES: Enzalutamide improves mHSPC survival regardless of baseline PSA
User login
Username
Password
Reset your password
/content/arches-enzalutamide-improves-mhspc-survival-regardless-baseline-psa
/oncologypractice/article/200291/genitourinary-cancer/arches-enzalutamide-improves-mhspc-survival
/hematology-oncology/article/200291/genitourinary-cancer/arches-enzalutamide-improves-mhspc-survival